Interestingly, RANTES/CCL5 had no inducing effect on MMP-1 and MMP-13 expression in OASFs (Figure 1C) or in the human dermal fibroblasts (data now shown), suggesting that RANTES/CCL5 preferentially inflicts tissue damage in RA. This evidence concerns the gene CCL5 and rheumatoid arthritis.